Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 427, Issue 1-2, Pages 123-131Publisher
SPRINGER
DOI: 10.1007/s11010-016-2904-x
Keywords
hnRNPA1; Autoregulation; Splicing; Cell death
Categories
Funding
- Japan Society for the Promotion of Science [15H04689, 25460342]
- Japan ALS association (JALSA)
- Naito Foundation Natural Science Scholarship
- Akaeda Medical Research Foundation
- Grants-in-Aid for Scientific Research [15H04689, 25460342] Funding Source: KAKEN
Ask authors/readers for more resources
Heterogeneous nuclear ribonucleoprotein (hnRNP)A1, a member of the hnRNP family, is involved in a variety of RNA metabolisms. The hnRNPA1 expression is altered in some human diseases and mutations of the hnRNPA1 gene cause amyotrophic lateral sclerosis and multisystem proteinopathy. It has been therefore assumed that the dysregulation of hnRNPA1 is linked to the pathogenesis of the diseases. However, the mechanism underlying the regulation of the hnRNPA1 expression remains unknown. In this study, using cell-based models, we have found that hnRNPA1 negatively regulates its own mRNA expression by inhibiting the intron10 splicing of hnRNPA1 pre-mRNA. This mechanism likely serves as an autoregulation of the hnRNPA1 expression. We have also found that a low-grade excess of hnRNPA1 expression causes cytotoxicity by activating the mitochondrial apoptosis pathway. Collectively, these data suggest that the level of hnRNPA1 is strictly controlled to be within a certain range by the mRNA autoregulation in the physiological condition so that the cytotoxicity-causative alteration of hnRNPA1 expression does not take place.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available